← Back to Search

Behavioural Intervention

Green Environment for Community Health Improvement (HEAL Trial)

N/A
Recruiting
Led By Rachel Keith, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
30-70 years of age
Be older than 18 years old
Must not have
HIV/AIDS, active treatment for cancer, active bleeding including wounds
Body weight less than 100 pounds or BMI>40
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 2 year followup
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how the environment and neighborhood characteristics affects the health of the area residents.

Who is the study for?
This trial is for individuals aged 30-70 living in a specific study area, who are not prisoners or part of other vulnerable groups. Participants must be able to consent and should not have HIV/AIDS, active cancer treatment, active bleeding issues, weigh less than 100 pounds or have a BMI over 40.
What is being tested?
The study investigates the impact of neighborhood green spaces on heart health and well-being. It aims to understand how environmental changes like increased greenery can influence cardiovascular disease risk and metabolic health.
What are the potential side effects?
Since this intervention involves environmental changes rather than medical treatments, traditional side effects are not expected. However, there may be indirect effects on lifestyle or well-being due to alterations in neighborhood characteristics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 70 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have HIV/AIDS, am not currently being treated for cancer, and do not have any active bleeding or wounds.
Select...
I weigh less than 100 pounds or my BMI is over 40.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 2 year followup
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 2 year followup for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Secondary study objectives
Body fat
Body lean mass
Bucchal swab
+25 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Targeted neighborhoods for GreennessExperimental Treatment1 Intervention
Using greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting.
Group II: Control GroupActive Control1 Intervention
No intervention

Find a Location

Who is running the clinical trial?

The Nature ConservancyUNKNOWN
University of LouisvilleLead Sponsor
348 Previous Clinical Trials
76,543 Total Patients Enrolled
National Institute of Environmental Health Sciences (NIEHS)NIH
291 Previous Clinical Trials
1,233,613 Total Patients Enrolled
Rachel Keith, PhDPrincipal Investigator - University of Louisville
University Of Louisville School Of Medicine (Medical School)
Aruni Bhatnagar, PhDStudy DirectorUniversity of Louisville

Media Library

Greenness as a therapeutic intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03670524 — N/A
Cardiovascular Disease Research Study Groups: Control Group, Targeted neighborhoods for Greenness
Cardiovascular Disease Clinical Trial 2023: Greenness as a therapeutic intervention Highlights & Side Effects. Trial Name: NCT03670524 — N/A
Greenness as a therapeutic intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03670524 — N/A
~85 spots leftby Oct 2025